Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
CSA C22.2 No. 60601-2-31-09 amd1-2014 (2019) is the Canadian adoption of the international standard IEC 60601-2-31, with specific modifications for the Canadian regulatory environment. This standard establishes particular requirements for the basic safety and essential performance of external cardiac pacemakers that incorporate an internal power source. It applies to devices intended for use in professional healthcare facilities, patient transport, and home healthcare environments.
The standard covers pacemakers that deliver electrical impulses to the heart via external electrodes (transcutaneous pacing) or through temporary pacing leads (epicardial or endocardial). It does not apply to implantable pacemakers, implantable cardioverter-defibrillators, or devices used solely for diagnostic purposes. The scope includes devices that are battery-powered, line-powered via external power supply, or both.
As part of the CSA C22.2 series (Canadian Electrical Code, Part II), this standard is recognized by provincial and territorial regulatory authorities. The amendment (amd1) published in 2014 and reaffirmed in 2019 introduces clarified requirements for protection against electrical hazards, enhanced alarm systems, and updated marking and documentation provisions aligned with the latest revisions of IEC 60601-1 and IEC 60601-1-2.
The standard defines essential performance characteristics that must be maintained under normal and single-fault conditions. For external pacemakers, these include the accuracy and stability of pacing output parameters, the reliability of monitoring functions, and the proper operation of alarm systems. Key technical requirements are summarized in the table below.
| Requirement | Parameter / Criteria | Applicable Clause |
|---|---|---|
| Pulse Amplitude Accuracy | ±10 % or ±10 mA (whichever greater) for constant-current output; ±10 % for constant-voltage output | 201.12.4.101 |
| Pulse Width Accuracy | ±10 % of setting | 201.12.4.102 |
| Pacing Rate Accuracy | ±2 % of setting | 201.12.4.103 |
| Patient Leakage Current | ≤ 10 μA (normal condition); ≤ 50 μA (single-fault condition) | 201.8.7.4 |
| Alarm Systems | Audible and visual alarms for lead disconnect, low battery, and output disable; alarm latency ≤ 5 s for critical conditions | 201.12.4.201 – 201.12.4.206 |
| Electromagnetic Compatibility (EMC) | Immunity to radiated RF fields (80 MHz – 2.5 GHz) at 20 V/m; emissions per CISPR 11 Group 1 Class A | 201.6.1.2, IEC 60601-1-2 |
Additional requirements address the biological compatibility of patient-applied materials (per ISO 10993 series), sterilization of reusable components, and software validation for programmable devices. The standard also mandates a risk management process in accordance with ISO 14971, ensuring that all hazards (electrical, mechanical, thermal, and radiation) are identified and mitigated.
Manufacturers seeking compliance with CSA C22.2 No. 60601-2-31-09 amd1-2014 (2019) should integrate the requirements into their design control and quality management systems (ISO 13485). Key design considerations include:
To demonstrate compliance, manufacturers must submit a test report from an accredited laboratory (e.g., CSA, UL, Intertek) demonstrating conformity with all applicable clauses of the standard. The certification process typically includes:
CSA Group maintains a list of certified products under this standard. Devices bearing the CSA mark may be marketed across Canada without additional provincial testing. It is important to note that the standard references the general standard IEC 60601-1 (third edition) and collateral standards such as IEC 60601-1-2 (fourth edition), which together form a comprehensive safety framework.
Article last reviewed: December 2026